DE60019722D1 - Pharmazeutische zusammensetzungen zur unbehagenverminderung - Google Patents
Pharmazeutische zusammensetzungen zur unbehagenverminderungInfo
- Publication number
- DE60019722D1 DE60019722D1 DE60019722T DE60019722T DE60019722D1 DE 60019722 D1 DE60019722 D1 DE 60019722D1 DE 60019722 T DE60019722 T DE 60019722T DE 60019722 T DE60019722 T DE 60019722T DE 60019722 D1 DE60019722 D1 DE 60019722D1
- Authority
- DE
- Germany
- Prior art keywords
- products
- pharmaceutical compositions
- prevention
- infants
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 abstract 1
- 229960003987 melatonin Drugs 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 230000036642 wellbeing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9920011 | 1999-01-20 | ||
EP99200166 | 1999-01-20 | ||
NL9929041 | 1999-04-29 | ||
EP99201359A EP0951842B1 (de) | 1999-01-20 | 1999-04-29 | Säuglingsnährpräparat |
PCT/NL2000/000042 WO2000043013A1 (en) | 1999-01-20 | 2000-01-20 | Pharmaceutical compositions for alleviating discomfort |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60019722D1 true DE60019722D1 (de) | 2005-06-02 |
DE60019722T2 DE60019722T2 (de) | 2005-11-17 |
Family
ID=26153242
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69904257T Expired - Lifetime DE69904257T2 (de) | 1999-01-20 | 1999-04-29 | Säuglingsnährpräparat |
DE60019722T Expired - Lifetime DE60019722T2 (de) | 1999-01-20 | 2000-01-20 | Pharmazeutische zusammensetzungen zur unbehagenverminderung |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69904257T Expired - Lifetime DE69904257T2 (de) | 1999-01-20 | 1999-04-29 | Säuglingsnährpräparat |
Country Status (11)
Country | Link |
---|---|
US (4) | US6900180B1 (de) |
EP (2) | EP0951842B1 (de) |
JP (2) | JP2002535277A (de) |
AT (2) | ATE228779T1 (de) |
AU (2) | AU2466500A (de) |
CA (2) | CA2359592C (de) |
DE (2) | DE69904257T2 (de) |
DK (1) | DK0951842T3 (de) |
ES (2) | ES2187115T3 (de) |
PT (1) | PT951842E (de) |
WO (2) | WO2000043013A1 (de) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE228779T1 (de) * | 1999-01-20 | 2002-12-15 | Nutricia Nv | Säuglingsnährpräparat |
GB9906740D0 (en) | 1999-03-23 | 1999-05-19 | Kilgowan Limited | Oral combinations of hydroxocobalamin and folic acid |
AU771754B2 (en) * | 1999-06-29 | 2004-04-01 | New Zealand Milk Institute Limited, The | Prophylactic dietary supplement based on milk |
US6627213B2 (en) * | 1999-08-20 | 2003-09-30 | Wisconsin Alumni Research Foundation | Inhibition of neonatal hyperbilirubinemia in breast fed infants |
US7208180B2 (en) | 2000-05-08 | 2007-04-24 | N.V. Nutricia | Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith |
JP2004526793A (ja) | 2001-04-25 | 2004-09-02 | コバルツ リミテッド | 個体における機能性ビタミンb12欠乏症を治療または予防するための方法、およびこの方法に使用するための医療用組成物 |
US20100268658A1 (en) * | 2001-05-14 | 2010-10-21 | Prolacta Bioscience | Method for collecting, testing and distributing milk |
US20030104033A1 (en) * | 2001-07-13 | 2003-06-05 | Lai Chon-Si | Enteral formulations |
NL1019368C2 (nl) * | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
US7651716B2 (en) | 2001-12-21 | 2010-01-26 | Wyeth Llc | Methods for reducing adverse effects of feeding formula to infants |
JP4521168B2 (ja) * | 2002-08-15 | 2010-08-11 | テルモ株式会社 | 血糖値上昇抑制用のビタミンb1含有栄養組成物 |
US7951410B2 (en) | 2003-04-14 | 2011-05-31 | Mead Johnson Nutrition Company | Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid |
US20040214791A1 (en) * | 2003-04-25 | 2004-10-28 | Nancy Auestad | High lactose infant nutrition formula |
JP4721631B2 (ja) * | 2003-09-30 | 2011-07-13 | 小林製薬株式会社 | 催眠剤組成物 |
CA2556753C (en) * | 2004-02-20 | 2014-11-25 | Lifescape Biosciences Incorporated | Compositions and methods for sleep regulation |
JP4891069B2 (ja) * | 2004-03-31 | 2012-03-07 | カルピス株式会社 | 内因性メラトニン分泌リズムの位相調整又は振幅増強剤、及び概日リズム改善剤 |
WO2005110124A1 (en) * | 2004-04-15 | 2005-11-24 | Abbott Laboratories | Composition and methods for nutritional management of patients with hepatic disease |
WO2005117592A1 (en) * | 2004-06-04 | 2005-12-15 | Devlin, Daniel, J. | Treatment of dermatological conditions |
ES2286558T5 (es) | 2004-08-24 | 2013-10-15 | N.V. Nutricia | Composición nutritiva que comprende transgalactooligosacáridos indigeribles y sacáridos de galactosa digeribles |
ES2259885B1 (es) * | 2004-09-29 | 2007-11-01 | Laboratorios Ordesa, S.L. | Kit nutricional infantil para regular el ciclo de sueño-vigilia. |
DE102005001645A1 (de) * | 2005-01-13 | 2006-07-20 | Gerhard Dr. Sauermann | Topisches Produkt zur Vorbeugung und Behandlung von Windeldermatitis |
EP1680967A1 (de) * | 2005-01-14 | 2006-07-19 | Forum Media Productions SPRL | Diätetische Zusammensetzungen auf Basis von löslichem Milchproteinisolat |
DE102005012060A1 (de) * | 2005-03-16 | 2006-09-21 | Gerhard Dr. Sauermann | Orales Produkt zur Vorbeugung und Behandlung von Windeldermatitis |
JP2006321742A (ja) * | 2005-05-18 | 2006-11-30 | Tokyo Medical & Dental Univ | 睡眠改善薬 |
EP1926834A4 (de) | 2005-09-20 | 2009-04-22 | Prolacta Bioscience Inc | Verfahren zum testen von milch |
GB2432772B (en) * | 2005-11-30 | 2011-06-01 | Sis | Improvements in and relating to nutritional products |
WO2007073194A2 (en) * | 2005-12-23 | 2007-06-28 | N.V. Nutricia | Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
ES2366034T3 (es) * | 2005-12-23 | 2011-10-14 | N.V. Nutricia | Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia. |
JP5430927B2 (ja) * | 2006-03-15 | 2014-03-05 | サントリーホールディングス株式会社 | リボフラビンとセサミン類とを含有する組成物 |
ES2330057T3 (es) * | 2006-03-23 | 2009-12-03 | N.V. Nutricia | Formula para prematuros. |
BRPI0601834A (pt) * | 2006-03-30 | 2007-11-27 | Ricardo De Souza Pereira | suplementação dietética para curar ou regredir sintomas de refluxo gastroesofágico, gastrite e úlceras |
US20070299127A1 (en) * | 2006-06-23 | 2007-12-27 | The Procter & Gamble Company | Compositions and kits comprising a melatonin component and an omega-3-fatty acid component |
US20080057144A1 (en) * | 2006-09-01 | 2008-03-06 | Cathy Beggan | Wake up on time dietary supplement and method of use |
DK2099321T3 (en) * | 2006-11-29 | 2017-07-17 | Prolacta Bioscience Inc | Human milk compositions and methods for their preparation and use |
WO2008073888A2 (en) * | 2006-12-08 | 2008-06-19 | Prolacta Bioscience, Inc. | Compositions of human lipids and methods of making and using same |
EP1932437A1 (de) * | 2006-12-15 | 2008-06-18 | Nestec S.A. | Kinderformel |
AU2008239318B2 (en) | 2007-03-15 | 2013-10-03 | Suntory Holdings Limited | Anti-fatigue agent |
WO2009091885A1 (en) * | 2008-01-16 | 2009-07-23 | Babak Baban | Health beverages comprising cinnamon extract and methods of making and using the same |
WO2009118726A2 (en) * | 2008-03-25 | 2009-10-01 | Pregnant Princess & Co. Ltd. | Oral combination of vitamins |
EP2271222B1 (de) * | 2008-04-29 | 2015-02-25 | DSM IP Assets B.V. | Verfahren für die zubereitung eines abgepackten, hitzekonservierten wässrigen getränks mit kasein-micellen und tryptophanreichen peptiden sowie auf diese weise erzeugtes produkt |
EP2282641B1 (de) | 2008-04-29 | 2012-08-29 | DSM IP Assets B.V. | Zusammensetzung mit kohlenhydraten und peptiden die tryptophan enthalten |
US20090286750A1 (en) * | 2008-05-16 | 2009-11-19 | Kasubick Robert V | Use of ribose in lessening the clinical symptoms of aberrant firing of neurons |
EA011075B1 (ru) * | 2008-06-20 | 2008-12-30 | Лев Михайлович МОГИЛЕВСКИЙ | Сухая молочная смесь |
JP5408261B2 (ja) * | 2008-11-26 | 2014-02-05 | アナトリエヴィチ ポミトキン,イーゴリ | うつ病、不安、統合失調症、睡眠障害、及びてんかん治療のためのコハク酸のコリン塩 |
ES2527959T3 (es) | 2008-12-02 | 2015-02-02 | Prolacta Bioscience, Inc. | Composiciones de permeado de leche humana y métodos para realizarlas y usarlas |
US9848760B2 (en) * | 2009-06-29 | 2017-12-26 | Gearbox, Llc | Devices for continual monitoring and introduction of gastrointestinal microbes |
US7862838B1 (en) * | 2009-08-31 | 2011-01-04 | Qing Si Zeng | Composition and regimen for the treatment of herpes simplex and herpes zoster primarily by eliminating their pathogenetic conditions and taking into account both pathogenesis and etiology |
US20120189563A1 (en) * | 2009-09-30 | 2012-07-26 | Shiseido Company, Ltd. | Oral composition for alleviating ultraviolet irradiation-induced damage |
AU2010331939B2 (en) * | 2009-12-18 | 2013-10-03 | Stokely-Van Camp, Inc. | Protein recovery beverage |
JP5094899B2 (ja) * | 2010-03-23 | 2012-12-12 | 小林製薬株式会社 | 催眠剤組成物 |
EP2554057A4 (de) | 2010-03-31 | 2013-12-18 | Vegenat S A | Enterale oder orale nahrungsmittelprodukte, im besonderen zur ernährung und prävention sowie verbesserung von neurologischen erkrankungen, neurodegenerativen erkrankungen oder kognitiven störungen |
WO2011121151A1 (es) | 2010-03-31 | 2011-10-06 | Vegenat, S.A. | Suplemento alimenticio funcional especialmente destinado para la nutrición, prevención y mejora en casos de alteraciones neurológicas, neurodegenerativas o trastornos cognitivos |
MX2013006353A (es) * | 2010-12-07 | 2013-08-26 | Nestec Sa | Metodos y composiciones utiles para promover el sueño en animales. |
PL2739157T3 (pl) | 2011-08-03 | 2018-03-30 | Prolacta Bioscience, Inc. | Mikrofiltracja ludzkiego mleka dla redukcji zanieczyszczenia bakteryjnego |
EP2583562A1 (de) * | 2011-10-21 | 2013-04-24 | Nestec S.A. | Verwendung von Molkeproteinmizellen für Kinder mit Adipositas- oder Diabetesrisiko |
WO2014007606A1 (en) | 2012-07-05 | 2014-01-09 | N.V. Nutricia | Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour |
AU2013298645B2 (en) * | 2012-07-31 | 2016-11-03 | Société des Produits Nestlé S.A. | Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD) |
US11122813B2 (en) | 2013-03-13 | 2021-09-21 | Prolacta Bioscience, Inc. | High fat human milk products |
JPWO2015099102A1 (ja) * | 2013-12-27 | 2017-03-23 | 富士フイルム株式会社 | 亜鉛含有睡眠改善剤、ノンレム睡眠時間増加剤及び鎮静剤 |
JP7356221B2 (ja) | 2015-12-30 | 2023-10-04 | プロラクタ バイオサイエンス,インコーポレイテッド | 術前及び術後のケアに有用なヒト乳製品 |
US11122833B1 (en) * | 2016-02-26 | 2021-09-21 | Michelle Ann Toothman | Infant formulas having vitamin complexes with enhanced bioavailability |
US10039805B1 (en) * | 2016-02-26 | 2018-08-07 | Michelle Ann Toothman | Infant formulas having vitamin complexes with enhanced bioavailability |
US10039765B1 (en) * | 2016-02-26 | 2018-08-07 | Michelle Ann Toothman | Vitamin supplement compositions with enhanced bioavailability |
US10617700B1 (en) * | 2016-02-26 | 2020-04-14 | Michelle Ann Toothman | Vitamin supplement compositions with enhanced bioavailability |
EP3400935A1 (de) * | 2017-05-12 | 2018-11-14 | Hospital Sant Joan de Deu | Betain zur verhinderung von adipositas |
CN107198078A (zh) * | 2017-06-05 | 2017-09-26 | 天津市德恒科技有限公司 | 黄疸期小肽生长营养素及工艺制造方法 |
US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
WO2020011629A1 (en) * | 2018-07-07 | 2020-01-16 | Ivica Cepanec | Composition of powderous instant drink, its preparation and use |
WO2020078718A1 (en) * | 2018-10-17 | 2020-04-23 | Frieslandcampina Nederland B.V. | Sleep-improving compositions |
RU2709500C1 (ru) * | 2019-10-15 | 2019-12-18 | Виктор Александрович Сисев | Фармацевтическая композиция для парентерального капельного введения |
US20220288125A1 (en) * | 2021-03-15 | 2022-09-15 | Stokely-Van Camp, Inc. | Nutritional Composition for Improving Sleep |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3390039A (en) * | 1964-10-09 | 1968-06-25 | Eastman Kodak Co | Method and apparatus for making additive filters |
US3415655A (en) * | 1965-10-19 | 1968-12-10 | Ajinomoto Kk | Milk product containing free amino acids and method of preparing the same |
US3930039A (en) * | 1971-07-30 | 1975-12-30 | Molkerei J A Meggle Milchindus | Method of preparing a protein concentrate from whey |
US4210637A (en) * | 1978-07-31 | 1980-07-01 | Massachusetts Institute Of Technology | Composition and method for suppressing appetite for calories as carbohydrates |
US4491589A (en) * | 1982-05-17 | 1985-01-01 | The Trustees Of Columbia University In The City Of New York | Amino acid solutions for parenteral nutrition and methods of formulation and use |
AU577049B2 (en) * | 1983-06-16 | 1988-09-15 | Farley Health Products Limited | Infant milk formula |
IT1212792B (it) | 1983-11-30 | 1989-11-30 | Egidio Aldo Moja | Supplemento dietetico e alimento preconfezionato che lo contiene procedimento di preparazione e metodo di somministrazione |
GB8523338D0 (en) * | 1985-09-20 | 1985-10-23 | Kreitzman S N | Treatment of obesity |
US4920098A (en) * | 1986-09-17 | 1990-04-24 | Baxter International Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases |
US5631271A (en) * | 1986-11-29 | 1997-05-20 | Serfontein; Willem J. | Methods and preparations for the treatment and prophylaxis of metabolic disturbances |
GB8900924D0 (en) * | 1989-01-17 | 1989-03-08 | Amco Chemie Handel | Compositions for use in enzyme deficiencies |
US5053429A (en) * | 1988-04-08 | 1991-10-01 | The Lithox Corporation, Inc. | Treating inflammatory pain with methionine |
CA1333471C (en) * | 1988-04-29 | 1994-12-13 | Gustavo Bounous | Whey protein concentrate as food supplement |
US5075290A (en) * | 1989-06-28 | 1991-12-24 | University Of Virginia Alumni Patents Foundation | Use of adenosine, adenosine analogs or nucleoside uptake blockers, e.g. dipyridamole, as drug treatments for obstructive sleep apnea and snoring |
FR2657013B1 (fr) | 1990-01-18 | 1992-05-15 | Medgenix Group Sa | Composition dietetique a base de polypeptides et acides amines. |
US5132113A (en) * | 1990-10-26 | 1992-07-21 | Maurizio Luca | Nutritional composition containing essential amino acids |
IT1247125B (it) * | 1991-03-01 | 1994-12-12 | Depha Team Srl | Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco. |
DE122007000073I1 (de) * | 1991-05-09 | 2008-01-31 | Neurim Pharma 1991 | Melatonin enthaltene Arzneimittel |
DE4130284A1 (de) * | 1991-09-12 | 1993-03-18 | Willi Prof Dr Med Habil Heine | Verfahren zur herstellung biologisch hochwertiger nahrungseiweisse |
AP387A (en) | 1991-09-13 | 1995-07-31 | Siegbert Heinrich Bissbort | Therapeutical uses of L-methionine and compositions thereof. |
US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
CA2105881A1 (en) * | 1992-09-14 | 1994-03-15 | Willem Jacob Serfontein | Compositions for the treatment and prophylaxis of metabolic disturbances in infants |
DE4326675C2 (de) | 1993-08-09 | 1996-12-12 | Puetter Medice Chem Pharm | Verwendung einer Kombination aus Folsäure, Vitamin B¶6¶ und Vitamin B¶1¶¶2¶ zur Vorbeugung von Nervendegenerationserkrankungen und Altersdementia |
US5700590A (en) * | 1994-01-10 | 1997-12-23 | Abbott Laboratories | Nutritional formula with ribo-nucleotides |
US5691325A (en) * | 1994-01-14 | 1997-11-25 | Sandyk; Reuven | Method for ameliorating age-related disease conditions |
US20070231402A1 (en) * | 1994-08-02 | 2007-10-04 | Immunopath Profile, Inc. | Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof |
US5549905A (en) * | 1994-10-18 | 1996-08-27 | Clintec Nutrition Co. | Enternal composition for pediatric patients |
US5589468A (en) * | 1995-01-13 | 1996-12-31 | Clintec Nutrition Co. | Method for providing nutrition to elderly patients |
CA2141126A1 (en) | 1995-01-26 | 1996-07-27 | Natalie J. Lazarowych | Combinational drug for treating migraine and other illnesses |
US5728678A (en) * | 1995-06-06 | 1998-03-17 | Nestec Ltd. | Method and composition for providing nutrition to a renal failure patient |
DE69506095T2 (de) * | 1995-08-04 | 1999-06-24 | Nutricia Nv | Diätfasern enthaltende Nahrungszusammensetzung |
US5635199A (en) * | 1995-10-27 | 1997-06-03 | Nestec Ltd. | Support of pediatric patients |
US5801159A (en) * | 1996-02-23 | 1998-09-01 | Galileo Laboratories, Inc. | Method and composition for inhibiting cellular irreversible changes due to stress |
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
US6221836B1 (en) * | 1996-07-26 | 2001-04-24 | Paxton King Beale | Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal |
SK16399A3 (en) * | 1996-08-09 | 2000-09-12 | Mannatech Inc | Compositions of plant carbohydrates as dietary supplements |
FR2754181B1 (fr) | 1996-10-03 | 1998-12-04 | Oenobiol S A Lab | Nouvelles utilisations de compositions a base d'alpha-lactalbumine |
GB9701675D0 (en) * | 1997-01-28 | 1997-03-19 | Bridgeman Keith | Composition for the treatment of parkinson's disease |
US5922766A (en) * | 1997-07-02 | 1999-07-13 | Acosta; Phyllis J. B. | Palatable elemental medical food |
EP0891719A1 (de) | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Narungszusammensetzungen mit Gehalt an Methionin |
US6395876B1 (en) * | 1997-12-05 | 2002-05-28 | Medical College Of Georgia Research Institute, Inc. | High-affinity tryptophan transporter |
US5817695A (en) * | 1997-12-24 | 1998-10-06 | Pellico; Michael A. | Nutritional product with high fat, low carbohydrate and amino acid imbalance |
US6048846A (en) * | 1998-02-26 | 2000-04-11 | Cochran; Timothy M. | Compositions used in human treatment |
US6475539B1 (en) * | 1998-05-07 | 2002-11-05 | Abbott Laboratories | Nutritionally complete low pH enteral formula |
ATE228779T1 (de) * | 1999-01-20 | 2002-12-15 | Nutricia Nv | Säuglingsnährpräparat |
US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
US7226916B1 (en) * | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
US20020147153A1 (en) * | 2001-02-14 | 2002-10-10 | Functional Foods, Inc. | Nutritional supplement to alleviate symptoms associated with reduced levels of serotonin |
US6660293B2 (en) * | 2001-06-29 | 2003-12-09 | Everett Laboratories, Inc. | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects |
US7867541B2 (en) * | 2003-04-14 | 2011-01-11 | Mead Johnson Nutrition Company | Compositions and methods of formulation for enteral formulas containing sialic acid |
ES2366034T3 (es) * | 2005-12-23 | 2011-10-14 | N.V. Nutricia | Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia. |
-
1999
- 1999-04-29 AT AT99201359T patent/ATE228779T1/de active
- 1999-04-29 DE DE69904257T patent/DE69904257T2/de not_active Expired - Lifetime
- 1999-04-29 DK DK99201359T patent/DK0951842T3/da active
- 1999-04-29 PT PT99201359T patent/PT951842E/pt unknown
- 1999-04-29 EP EP99201359A patent/EP0951842B1/de not_active Expired - Lifetime
- 1999-04-29 ES ES99201359T patent/ES2187115T3/es not_active Expired - Lifetime
-
2000
- 2000-01-20 AT AT00903030T patent/ATE293974T1/de active
- 2000-01-20 CA CA002359592A patent/CA2359592C/en not_active Expired - Lifetime
- 2000-01-20 CA CA2627837A patent/CA2627837C/en not_active Expired - Lifetime
- 2000-01-20 ES ES00903030T patent/ES2240060T3/es not_active Expired - Lifetime
- 2000-01-20 AU AU24665/00A patent/AU2466500A/en not_active Abandoned
- 2000-01-20 JP JP2000594467A patent/JP2002535277A/ja active Pending
- 2000-01-20 AU AU24666/00A patent/AU2466600A/en not_active Abandoned
- 2000-01-20 EP EP00903030A patent/EP1143974B1/de not_active Revoked
- 2000-01-20 US US09/889,793 patent/US6900180B1/en not_active Expired - Lifetime
- 2000-01-20 WO PCT/NL2000/000042 patent/WO2000043013A1/en active IP Right Grant
- 2000-01-20 WO PCT/NL2000/000043 patent/WO2000042868A1/en active Application Filing
- 2000-01-20 US US09/889,691 patent/US6613367B1/en not_active Expired - Lifetime
- 2000-01-20 DE DE60019722T patent/DE60019722T2/de not_active Expired - Lifetime
-
2005
- 2005-05-10 US US11/125,201 patent/US8124585B2/en not_active Expired - Fee Related
-
2007
- 2007-07-18 JP JP2007187280A patent/JP2007291135A/ja active Pending
-
2008
- 2008-02-19 US US12/033,379 patent/US8450347B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20050256031A1 (en) | 2005-11-17 |
DE69904257D1 (de) | 2003-01-16 |
US6900180B1 (en) | 2005-05-31 |
AU2466600A (en) | 2000-08-07 |
US20080145451A1 (en) | 2008-06-19 |
ATE293974T1 (de) | 2005-05-15 |
WO2000042868A1 (en) | 2000-07-27 |
PT951842E (pt) | 2003-04-30 |
JP2007291135A (ja) | 2007-11-08 |
JP2002535277A (ja) | 2002-10-22 |
US8450347B2 (en) | 2013-05-28 |
EP0951842A2 (de) | 1999-10-27 |
DK0951842T3 (da) | 2003-01-06 |
EP0951842A3 (de) | 1999-12-22 |
EP1143974B1 (de) | 2005-04-27 |
DE69904257T2 (de) | 2003-04-17 |
CA2359592A1 (en) | 2000-07-27 |
EP1143974A1 (de) | 2001-10-17 |
AU2466500A (en) | 2000-08-07 |
US6613367B1 (en) | 2003-09-02 |
CA2359592C (en) | 2008-07-29 |
US8124585B2 (en) | 2012-02-28 |
CA2627837A1 (en) | 2000-07-27 |
CA2627837C (en) | 2013-09-10 |
ES2187115T3 (es) | 2003-05-16 |
ATE228779T1 (de) | 2002-12-15 |
WO2000043013A1 (en) | 2000-07-27 |
DE60019722T2 (de) | 2005-11-17 |
ES2240060T3 (es) | 2005-10-16 |
EP0951842B1 (de) | 2002-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60019722D1 (de) | Pharmazeutische zusammensetzungen zur unbehagenverminderung | |
PT1411960E (pt) | Produto alimentar enriquecido a base de farelo de arroz para promocao da saude cardiovascular | |
CY1110353T1 (el) | Ανοσορρυθμιστικοι ολιγοσακχαριτες | |
BR9712259A (pt) | Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo. | |
DE60229286D1 (de) | Lebensmittel oder tierfutter enthaltend die knochengesundheit unterstützendes pflanzenextrakt aus amelanchier | |
BR0214838A (pt) | Composição para promoção de crescimento ósseo e manutenção da saúde óssea | |
Craenen et al. | An appraisal of folates as key factors in cognition and ageing-related diseases | |
DE59107336D1 (de) | Oligosaccharidderivate und deren Verwendung in Heilmitteln | |
DE60235418D1 (de) | Osteoprotegerin in Milch | |
Pallewad et al. | Vitamin D deficiency: how prevalent it is? | |
Beighton et al. | CANAVAN, Myrtelle M. 1879–1955 | |
UA6404U (en) | Method for stimulating mental abilities in children | |
UA31379A (uk) | Спосіб лікування ішемічної хвороби серця |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |